SightfileU.S. market data from official filings

Companies › BCTX

BRIACELL THERAPEUTICS CORP (BCTX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001610820 · EDGAR filings · Updated 2026-06-26

BRIACELL THERAPEUTICS CORP (BCTX) has reported institutional ownership of 4.4%, with 15 institutional managers holding positions valued at $3.70M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
4.4%
Institutional managers
15
Reported 13F value
$3.70M
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BRIACELL THERAPEUTICS CORP has 15 institutional holders and institutional ownership of 4.4%.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-06-09 (recurring since 2024-10-29) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2024-08-23 (recurring since 2024-07-05) — source filing. The authoritative details are those stated in the filing itself.

Related companies

FEMASYS INC (FEMY) · Incannex Healthcare Inc (IXHL) · PRECIPIO INC (PRPO) · TIZIANA LIFE SCIENCES LTD (TLSA) · Rockwell Medical Inc (RMTI) · ENLIVEX LTD COM (ENLV)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-26.